PHSI-BRG
PHSI-BRG
Home
Staff
Sarah Al Ashmori
Theophile Bigirumurame
Andy Bryant
Thomas Chadwick
Svetlana Cherlin
Mike Cole
Holly Fisher
Tony Fouweather
Shaun Hiu
Dorcas Kareithi
Ann Breeze Konkoth
Nan Lin
Jingky Lozano-Kuehne
Helen Mossop
Ellen Moss
Jérémie Nsengimana
Vicky Ryan
Marzieh Shahmandi
Moha Shojaei
Dawn Teare
James Wason
Faye Williamson
Nina Wilson
Sylvia Zhang
PhD students
Ruqayya Azher
Nicole Cizauskas
Laura Etfer
Niamh Fitzgerald
Raiann Hamshaw
Aritra Mukherjee
Pela Okorie
Samuel Sarkodie
Lou Whitehead
Methodology research
Overview
Adaptive designs
Master protocols
Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures
Leveraging External Information
Precision Medicine Clinical Trials
Contact
Light
Dark
Automatic
Residual Disease After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer: Network Meta-analysis Incorporating Expert Elicitation to Adjust for Publication Bias
Andrew Bryant
,
Michael Grayling
,
Ahmed Elattar
,
Ketankumar Gajjar
,
Dawn Craig
,
Luke Vale
,
Raj Naik
August 2022
Cite
DOI
URL
Type
Journal article
Publication
American Journal of Therapeutics
Bryant
Related
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review
Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis
Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer′s disease: A systematic review and meta-analysis
Ivermectin for prevention and treatment of COVID-19 infection: A systematic review, meta-analysis, and trial sequential analysis to inform clinical guidelines
Rituximab is ineffective for treatment of fatigue in primary biliary cholangitis: A phase 2 randomized controlled trial
Cite
×